AMBALAL SARABHAI ENTERPRISES
|
The Current P/S Ratio of AMBALAL SARABHAI ENTERPRISES is 1.04.
| Share Price | ₹26.5 | Jan 16,2026 |
| Market Cap | ₹203.1 Cr | |
| Sales-TTM | ₹195.6 Cr | TTM-Consolidated Results |
| Price/Sales | 1.04x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of AMBALAL SARABHAI ENTERPRISES
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹203.1 Cr] as on Jan 16,2026
(/) Sales [ ₹195.6 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 1.04x ]
Thus, for AMBALAL SARABHAI ENTERPRISES , the investors are currently willing to pay '1.04 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of AMBALAL SARABHAI ENTERPRISES !
The chart below summarizes the trend in P/S Ratio of AMBALAL SARABHAI ENTERPRISES over the last five years.
Historical PS (Price/Sales) ratio chart of AMBALAL SARABHAI ENTERPRISES
PS Ratio Performance Analysis for AMBALAL SARABHAI ENTERPRISES
- AMBALAL SARABHAI ENTERPRISES 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 1.30x.
- AMBALAL SARABHAI ENTERPRISES 's operated at median p/e ratio of 1.36x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, AMBALAL SARABHAI ENTERPRISES 's p/e ratio peaked in Mar2024 at 2.01x.
- AMBALAL SARABHAI ENTERPRISES 's p/e ratio hit its five-year low in Mar2021 of 0.83x.
How does AMBALAL SARABHAI ENTERPRISES 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| AMBALAL SARABHAI ENTERPRISES | 195.6 | 1.04 | 203.1 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 54,964.0 | 7.29 | 400,497.0 |
| DIVIS LABORATORIES LTD | 10,029.0 | 16.50 | 165,492.0 |
| CIPLA LTD | 28,349.6 | 3.98 | 112,922.0 |
| TORRENT PHARMACEUTICALS LTD | 12,248.0 | 11.10 | 136,013.0 |
| DR REDDYS LABORATORIES LTD | 34,310.0 | 2.86 | 98,115.0 |
| MANKIND PHARMA LTD | 13,576.9 | 6.62 | 89,832.6 |
| ZYDUS LIFESCIENCES LTD | 24,493.9 | 3.57 | 87,321.0 |
| LUPIN LTD | 24,750.7 | 4.02 | 99,410.8 |
| AUROBINDO PHARMA LTD | 32,514.5 | 2.09 | 68,087.4 |
| ABBOTT INDIA LTD | 6,714.4 | 8.79 | 59,024.1 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs AMBALAL SARABHAI ENTERPRISES 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 1.04x |
| Max industry PS | 16.50x |
| Median industry PS | 4.02x |
| Average industry PS | 6.17x |
You may also like the below Video Courses